Immediate Impact
50 standout
Citing Papers
Neoadjuvant Chemoimmunotherapy for NSCLC
2024 Standout
Non-small-cell lung cancer
2024 Standout
Works of C. Coronado Erdmann being referenced
LBA1 CheckMate 77T: Phase III study comparing neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) vs neoadjuvant placebo plus chemo followed by surgery and adjuvant NIVO or placebo for previously untreated, resectable stage II–IIIb NSCLC
2023 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| C. Coronado Erdmann | 205 | 85 | 62 | 12 | 322 | |
| R. Pfeiffer | 190 | 15 | 38 | 16 | 353 | |
| William Brannon | 45 | 101 | 60 | 16 | 339 | |
| S H Foo | 108 | 87 | 21 | 12 | 362 | |
| S Hirai | 157 | 44 | 12 | 23 | 312 | |
| Li Sun | 53 | 85 | 54 | 23 | 347 | |
| Y. K. Kim | 150 | 23 | 11 | 16 | 325 | |
| Cataldo D’Amore | 184 | 48 | 11 | 10 | 329 | |
| Norma Di Benedetto | 217 | 27 | 9 | 8 | 334 | |
| Yoshimitsu Doi | 112 | 12 | 39 | 15 | 336 | |
| Ernesto Cason | 214 | 33 | 13 | 13 | 364 |
All Works
Loading papers...